MoonLake Immunotherapeutics - Ordinary Shares - Class A

NASDAQ:MLTX   4:00:00 PM EDT
48.90
-0.04 (-0.08%)
: $48.21 -0.69 (-1.41%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

MoonLake Immunotherapeutics - Ordinary Shares - Class A Stock, NASDAQ:MLTX

Dorfstrasse 29, 52nd floor, Zug, Zug 6300
Switzerland
Phone: +41.510.80.22
Number of Employees: 50
http://www.moonlaketx.com

Description

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.